Barinthus Biotherapeutics (BRNS) Intangibles (2021 - 2026)
Barinthus Biotherapeutics (BRNS) recorded Intangibles of $13.05 million in Q2 2026, down 35.9% from $20.37 million a year earlier and down 4.5% from the prior quarter.
Barinthus Biotherapeutics (BRNS) Intangibles (2021 - 2026) Analysis & Trends
At the end of FY2025, Barinthus Biotherapeutics reported Intangibles of $14.29 million, down 34.9% from FY2024.
- Annual Intangibles has declined for four straight years, with a four-year compound annual growth rate of -17.9% (FY2021 to FY2025).
- Across earlier years, Intangibles came in at $21.95 million in FY2024 (-12.6%), $25.11 million in FY2023 (-11.2%), $28.27 million in FY2022 (-10.1%) and $31.43 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Intangibles in data going back to Q4 2021.
- On a year-over-year basis, Intangibles has declined for 15 consecutive quarters, with an average decline of 24.0% over the last eight quarters.
- Over the past five years, the year-over-year decline in Intangibles ranged from 10.1% (Q4 2022) to 35.9% (Q2 2026).
- Per Business Quant, the preceding three quarters came in at $13.67 million (Q1 2026), $14.29 million (Q4 2025) and $14.91 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Barinthus Biotherapeutics | 30.23 Mn | 30.29 Mn | - | 13.05 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.05 Mn |
| Mar 31, 2026 | 13.67 Mn |
| Dec 31, 2025 | 14.29 Mn |
| Sep 30, 2025 | 14.91 Mn |
| Jun 30, 2025 | 20.37 Mn |
| Mar 31, 2025 | 21.16 Mn |
| Dec 31, 2024 | 21.95 Mn |
| Sep 30, 2024 | 22.74 Mn |
| Jun 30, 2024 | 23.53 Mn |
| Mar 31, 2024 | 24.32 Mn |
| Dec 31, 2023 | 25.11 Mn |
| Sep 30, 2023 | 25.90 Mn |
| Jun 30, 2023 | 26.69 Mn |
| Mar 31, 2023 | 27.48 Mn |
| Dec 31, 2022 | 28.27 Mn |
| Sep 30, 2022 | 29.06 Mn |
| Jun 30, 2022 | 29.85 Mn |
| Mar 31, 2022 | 30.64 Mn |
| Dec 31, 2021 | 31.43 Mn |
Barinthus Biotherapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=BRNS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "BRNS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=BRNS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();